Page last updated: 2024-08-21

oxazoles and maytansine

oxazoles has been researched along with maytansine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Cruz-Monserrate, Z; Hamel, E; Harran, PG; Mullaney, JT; Pettit, GR	1
Altmann, KH; Bucher, P; Díaz, JF; Irschik, H; Jansen, R; Lucena-Agell, D; Menchon, G; Müller, R; Paterson, I; Prota, AE; Steinmetz, MO	1
Allingham, JS; Craig, AW; Evans, PA; Nersesian, S; Newsted, D; Shah, K; Williams, R; Young, S	1
Gelmon, KA; Tesch, ME	1

Reviews

1 review(s) available for oxazoles and maytansine

Article	Year
Targeting HER2 in Breast Cancer: Latest Developments on Treatment Sequencing and the Introduction of Biosimilars. Drugs, 2020, Volume: 80, Issue:17 Topics: Ado-Trastuzumab Emtansine; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biosimilar Pharmaceuticals; Breast; Breast Neoplasms; Camptothecin; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Disease-Free Survival; Female; Humans; Immunoconjugates; Lapatinib; Mastectomy; Maytansine; Medical Oncology; Molecular Targeted Therapy; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Oxazoles; Practice Guidelines as Topic; Pyridines; Quinazolines; Quinolines; Receptor, ErbB-2; Trastuzumab	2020

Article

Year

Targeting HER2 in Breast Cancer: Latest Developments on Treatment Sequencing and the Introduction of Biosimilars.

Drugs, 2020, Volume: 80, Issue:17

Topics: Ado-Trastuzumab Emtansine; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biosimilar Pharmaceuticals; Breast; Breast Neoplasms; Camptothecin; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Disease-Free Survival; Female; Humans; Immunoconjugates; Lapatinib; Mastectomy; Maytansine; Medical Oncology; Molecular Targeted Therapy; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Oxazoles; Practice Guidelines as Topic; Pyridines; Quinazolines; Quinolines; Receptor, ErbB-2; Trastuzumab

2020

Other Studies

3 other study(ies) available for oxazoles and maytansine

Article	Year
Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel-Dreyer chromatography. European journal of biochemistry, 2003, Volume: 270, Issue:18 Topics: Animals; Binding Sites; Cattle; Chromatography, Gel; Colchicine; Depsipeptides; Heterocyclic Compounds, 4 or More Rings; Kinetics; Maytansine; Oligopeptides; Oxazoles; Protein Binding; Protein Structure, Tertiary; Tritium; Tubulin; Vinblastine; Vincristine	2003
A fluorescence anisotropy assay to discover and characterize ligands targeting the maytansine site of tubulin. Nature communications, 2018, 05-29, Volume: 9, Issue:1 Topics: Ado-Trastuzumab Emtansine; Animals; Antineoplastic Agents; Binding Sites; Fluorescence Polarization; Humans; Ligands; Macrolides; Maytansine; Microtubules; Oxazoles; Trastuzumab; Tubulin	2018
Effects of Modulating Actin Dynamics on HER2 Cancer Cell Motility and Metastasis. Scientific reports, 2018, 11-22, Volume: 8, Issue:1 Topics: Ado-Trastuzumab Emtansine; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Synergism; Female; Humans; Lung Neoplasms; Marine Toxins; Maytansine; Mice; Ovarian Neoplasms; Oxazoles; Receptor, ErbB-2; Trastuzumab; Xenograft Model Antitumor Assays	2018